The Evolving Role of High Efficacy, Anti-CD40 Therapeutics for Relapsing Multiple Sclerosis

Jul 17, 2026

- Jul 16, 2027

0.5

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs)

This course is available for logged in users only. Please login or register to take the course.

Des experts internationaux évaluent de nouvelles données sur l’inhibition de l’aldostérone...

Integrating Next-Generation Acid Suppression into Practical Algorithms for Gastroenterolog...

PCSK9 Inhibitors in Primary Prevention: A New Paradigm for Family Physicians